HRMY (STOCKS)
Harmony Biosciences Holdings, Inc. Common Stock
$34.180000
-0.280000 (-0.81%)
Prev close: $34.460000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jeffrey M. Dayno
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,980.51M
- Employees
- 268
- P/E (TTM)
- 13.77
- P/B (TTM)
- 2.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
5
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.55 | $0.71 | -0.1579 | -22.31% |
|
Dec 2025 (Q4)
|
$0.38 | $0.91 | -0.5344 | -58.44% |
|
Sep 2025 (Q3)
|
$0.87 | $0.86 | +0.0139 | +1.62% |
|
Jun 2025 (Q2)
|
$0.68 | $0.77 | -0.0855 | -11.17% |
Financial Statements
| Revenues | $899.11M |
| Benefits Costs and Expenses | $701.53M |
| Cost Of Revenue | $210.86M |
| Costs And Expenses | $701.53M |
| Gross Profit | $688.25M |
| Operating Expenses | $498.73M |
| Research and Development | $224.44M |
| Other Operating Expenses | $274.30M |
| Operating Income/Loss | $189.52M |
| Income/Loss From Continuing Operations After Tax | $145.62M |
| Income/Loss From Continuing Operations Before Tax | $197.57M |
| Income Tax Expense/Benefit | $51.96M |
| Net Income/Loss | $145.62M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $145.62M |
| Net Income/Loss Available To Common Stockholders, Basic | $145.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.53 |
| Diluted Earnings Per Share | $2.49 |
| Basic Average Shares | 172,676,742 |
| Diluted Average Shares | 175,727,550 |
| Assets | $1.27B |
| Current Assets | $778.82M |
| Inventory | $5.28M |
| Prepaid Expenses | $16.80M |
| Other Current Assets | $756.74M |
| Noncurrent Assets | $493.01M |
| Intangible Assets | $83.46M |
| Other Non-current Assets | $409.55M |
| Liabilities | $361.48M |
| Current Liabilities | $217.34M |
| Accounts Payable | $28.60M |
| Wages | $6.73M |
| Other Current Liabilities | $182.01M |
| Noncurrent Liabilities | $144.14M |
| Long-term Debt | $158.81M |
| Equity | $910.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $910.35M |
| Liabilities And Equity | $1.27B |
| Net Cash Flow From Operating Activities | $341.97M |
| Net Cash Flow From Operating Activities, Continuing | $341.97M |
| Net Cash Flow From Investing Activities | -$225.66M |
| Net Cash Flow From Investing Activities, Continuing | -$225.66M |
| Net Cash Flow From Financing Activities | -$15.92M |
| Net Cash Flow From Financing Activities, Continuing | -$15.92M |
| Net Cash Flow | $100.40M |
| Net Cash Flow, Continuing | $100.40M |
| Comprehensive Income/Loss | $144.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $144.96M |
| Other Comprehensive Income/Loss | $89.98M |
| Other Comprehensive Income/Loss Attributable To Parent | -$658.00K |